Diclofenac is not a controlled substance. It carries no DEA schedule designation and has zero potential for the kind of physical dependence or euphoria associated with scheduled drugs like opioids or benzodiazepines. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID), the same broad class that includes ibuprofen and naproxen.
Why Diclofenac Isn’t Scheduled
The DEA places drugs on its controlled substances schedules (I through V) based on their potential for abuse, physical dependence, and whether they have accepted medical use. Diclofenac meets none of the criteria for scheduling. It works by blocking the production of prostaglandins, chemicals your body releases in response to injury or illness that trigger pain, swelling, and inflammation. This mechanism is fundamentally different from how opioids work. Opioids bind to receptors in the brain that produce pain relief alongside feelings of reward and euphoria, which is what makes them addictive. Diclofenac doesn’t interact with those reward pathways at all.
You won’t experience withdrawal symptoms if you stop taking diclofenac, and it produces no “high.” That’s the core reason it remains unscheduled, even though oral forms require a prescription.
Prescription vs. Over-the-Counter Forms
The fact that a drug requires a prescription doesn’t make it a controlled substance. Many non-controlled medications are prescription-only because they carry risks that warrant medical oversight. Diclofenac is a good example: some forms need a prescription, one doesn’t.
In the United States, diclofenac is the only FDA-approved topical NSAID, and it comes in several formulations with different access requirements:
- Voltaren Arthritis Pain gel (1%): Available over the counter for joint pain related to arthritis.
- Oral tablets (Voltaren, Cataflam): Prescription only. These include delayed-release and immediate-release versions of diclofenac sodium and diclofenac potassium.
- Topical solution (Pennsaid): Prescription only.
- Topical patch (Flector): Prescription only.
The prescription requirement for oral diclofenac exists because of specific safety risks, not because of abuse potential.
What Risks It Does Carry
Diclofenac’s risks are very different from those of controlled substances. Instead of addiction or overdose in the traditional sense, diclofenac carries two FDA boxed warnings, the most serious type of safety alert.
The first involves cardiovascular events. All NSAIDs raise the risk of heart attack and stroke, and this risk can appear early in treatment and increase the longer you use the drug. Diclofenac is contraindicated after coronary artery bypass graft surgery for this reason.
The second warning covers gastrointestinal bleeding. NSAIDs can cause bleeding, ulcers, and perforation in the stomach or intestines. These events can happen at any point during treatment and without warning symptoms. Older adults and people with a history of peptic ulcers or GI bleeding face the highest risk.
These are the reasons oral diclofenac remains behind the pharmacy counter as a prescription drug. The over-the-counter gel carries lower systemic risk because far less of the drug enters your bloodstream through the skin compared to swallowing a tablet.
How Pharmacies Handle It
Because diclofenac is not a controlled substance, pharmacies don’t apply the special handling rules that come with scheduled drugs. There’s no limit on the number of refills your doctor can authorize, no requirement for a new prescription each month, and no need for the pharmacist to check a prescription drug monitoring database before dispensing it. You also won’t need to show identification to pick it up, the way you would for certain controlled medications. If you’re picking up the OTC gel, you can simply grab it off the shelf.
Refills, quantity, and call-in prescriptions are all handled the same way as other routine prescription medications like blood pressure drugs or antibiotics. If your doctor prescribes oral diclofenac, the process is straightforward and involves none of the extra steps associated with controlled substances.